Effect of 5-{3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy}-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice

被引:35
作者
Abe, M
Nakai, H
Tabata, R
Saito, K
Egawa, M
机构
[1] Mitsubishi Chem Corp, Yokohama Res Ctr, Pharmaceut Lab 1, Aoba Ku, Yokohama, Kanagawa 2278502, Japan
[2] Mitsubishi Chem Corp, Yokohama Res Ctr, Pharmacokinet & Metab Res Lab, Aoba Ku, Yokohama, Kanagawa 2278502, Japan
[3] Mitsubishi Chem Corp, Dept Clin Res, Shinagawa Ku, Tokyo 1400002, Japan
关键词
MKC-242; 5-HT1A receptor; anxiolytic; aggressive behavior; marble burying behavior;
D O I
10.1254/jjp.76.297
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Behavioral effects of 5-{3-[((2S)-1,4-benzodioxan-2ymethyl)amino]propoxy}-1,3-benzo- dioxole HCI (MKC-242), a novel 5-HT1A-receptor agonist, were evaluated using animal models of anxiety and obsessive compulsive disorder and compared against reference compounds. MKC-242 suppressed foot shock-induced fighting behavior without loss of motor coordination in mice as the reference compounds did. The ED50 values of MKC-242, buspirone, tandospirone and diazepam were 1.7, 42, 80 and 2.0 mg/kg, p.o., respectively. The duration of the suppression of fighting by MKC-242 was longer than those of buspirone and tandospirone and comparable to that of diazepam. Similar results were also obtained with the water-lick conflict test in rats. The plasma concentration of MKC-242 in rats was much higher than the reported value of buspirone during 0.25-6 hr after oral administration. In addition, MKC-242 reduced marble burying behavior without reduction of motor activity. Fluoxetine, tandospirone and diazepam also reduced the behavior at non-sedative doses. These findings indicate that MKC-242 possesses a longer-lasting anxiolytic effect than azapirones. This might be due to the high concentration of the compound in plasma. In addition, it is also suggested that MKC-242 possesses an antiobsessional effect.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 31 条
[1]  
Abe M, 1996, J PHARMACOL EXP THER, V278, P898
[2]  
BARRETT JE, 1986, J PHARMACOL EXP THER, V238, P1009
[3]  
BLANCHARD DC, 1988, PHARMACOL BIOCHEM BE, V31, P269
[4]   MAJOR TRANQUILIZERS CAN BE DISTINGUISHED FROM MINOR TRANQUILIZERS ON THE BASIS OF EFFECTS ON MARBLE BURYING AND SWIM-INDUCED GROOMING IN MICE [J].
BROEKKAMP, CL ;
RIJK, HW ;
JOLYGELOUIN, D ;
LLOYD, KL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) :223-229
[5]   1-(2-PYRIMIDINYL)-PIPERAZINE AS ACTIVE METABOLITE OF BUSPIRONE IN MAN AND RAT [J].
CACCIA, S ;
CONTI, I ;
VIGANO, G ;
GARATTINI, S .
PHARMACOLOGY, 1986, 33 (01) :46-51
[6]  
GARATTINI S, 1991, BUSPIRONE MECHANISMS, P151
[7]   ALPHA-2-ADRENOCEPTOR ANTAGONIST ACTIVITY MAY ACCOUNT FOR THE EFFECTS OF BUSPIRONE IN AN ANTICONFLICT TEST IN THE RAT [J].
GOWER, AJ ;
TRICKLEBANK, MD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) :129-137
[8]   5-HT receptor classification and nomenclature: Towards a harmonization with the human genome [J].
Hoyer, D ;
Martin, G .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :419-428
[9]   5-HT1A-RECEPTOR SUBTYPE MEDIATES THE EFFECT OF FLUVOXAMINE, A SELECTIVE SEROTONIN REUPTAKE INHIBITOR, ON MARBLE-BURYING BEHAVIOR IN MICE [J].
ICHIMARU, Y ;
EGAWA, T ;
SAWA, A .
JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 68 (01) :65-70
[10]   OBSESSIVE-COMPULSIVE DISORDER AND SEROTONIN - IS THERE A CONNECTION [J].
INSEL, TR ;
MUELLER, EA ;
ALTERMAN, I ;
LINNOILA, M ;
MURPHY, DL .
BIOLOGICAL PSYCHIATRY, 1985, 20 (11) :1174-1188